Naltrexone pre-treatment attenuates ketamine-induced glutamatergic activity and antidepressant effects without affecting ketamine-induced changes in cerebral blood flow

Autor: Jelen, L.A., Lythgoe, D.J., O'Daly, O., Stone, J.M., Young, A.H., Mehta, M.A.
Zdroj: In Neuroscience Applied 2023 2 Supplement 2
Databáze: ScienceDirect